Videos

Benjamin Levy, MD, medical director, Thoracic Oncology, Mount Sinai Health System, discusses recent advances in the detection and diagnosis of lung cancer.

Sancy Leachman, MD, PhD, professor and chair, Department of Dermatology, director, Melanoma Research Program, Knight Cancer Institute, Oregon Health & Science University, discusses how a mobile app can help oncology professionals monitor patients for melanoma.

Phyllis McKiernan, MSN, APN, OCN, nurse practitioner, John Theurer Cancer Center at Hackensack University Medical Center, discusses new drug approvals for multiple myeloma and addressing adverse events. 

Carolyn Lefkowits, MD, MPH, MS, assistant professor, University of Colorado Denver, discusses the role of non-physician providers in gynecologic oncology. 

Patricia Kropf, MD, assistant professor, Division of Bone Marrow Transplants, Fox Chase Cancer Center, discusses home administration of Synribo (omacetaxine mepesuccinate).

Sagar Lonial, MD, chief medical officer, Winship Cancer Institute of Emory University and Professor and Executive Vice Chair, Department of Hematology and Medical Oncology, Emory University School of Medicine, discusses treating patients with myeloma.

Jonathan Trent, MD, PhD, associate director for clinical research, director of the Sarcoma Medical Research Program at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, discusses the approval of trabectedin to treat patients with soft tissue sarcoma. 

David Reardon, MD, clinical director, Center for Neuro-Oncology, Dana-Farber Cancer Institute, discusses caring for patients with glioblastoma.

Lee Greenberger, PhD, chief scientific officer, The Leukemia & Lymphoma Society, discusses new agents that were recently approved for multiple myeloma.

Jeffrey Jones, MD, MPH, assistant professor of Internal Medicine and section head of the Chronic Lymphocytic Leukemia (CLL) research program at Ohio State University Comprehensive Cancer Center, discusses how nurses can help patients comply with taking their oncology drugs.

Michael Soulen, MD, a professor of radiology and surgery at the Abramson Cancer Center, University of Pennsylvania, discusses radioembolization to treat liver metastases in patients with neuroendocrine tumors (NETs) as well as the efficacy of embolization in treating NETs.

Roger Lo, MD, PhD, UCLA Jonsson Comprehensive Cancer Center, discusses the evolution of metastatic melanoma during therapy.

Jennifer Montes, MD, New York University Medical Center, discusses the role of nurses in treating patients with breast cancer.

Mabel Ryder, MD, endocrinologist and medical oncologist, Mayo Clinic, discusses targeting the tumor microenvironment in thyroid cancer. 

Richard Joseph, MD, an oncologist at Mayo Clinic, discusses mucosal melanoma.

John Kirkwood, MD, Usher professor, Medicine, Dermatology and Translational Science, co-director, Melanoma and Skin Cancer Program, University of Pittsburgh, discusses training physicians on skin examinations for detecting melanoma. 

Sancy Leachman, MD, PhD, professor and chair, Department of Dermatology, director, Melanoma Research Program, Knight Cancer Institute, Oregon Health & Science University, discusses the mobile app Mole Mapper, which allows patients to measure and monitor their moles for melanoma.

Anita Nirenberg, PhD, RN, AOCNP, PNP-BC, FAAN, a professor of clinical nursing and associate director for Nurse Practitioner Specialties at Hunter-Bellevue School of Nursing, discusses pediatric oncology nursing.

Jennifer Temel, MD, clinical director of thoracic oncology at Massachusetts General Hospital, discusses screening for pain and other cancer-related symptoms.

Charles Loprinzi, MD, Giant of Cancer Care: Supportive/Palliative Care, Mayo Clinic, discusses potential treatments for chemotherapy-induced peripheral neuropathy (CIPN).

Aaron Spitz, MD, Orange County Urology Associates, discusses how telemedicine is expanding nurses' roles and responsibilities in caring for patients.

Kathrin Milbury, PhD, assistant professor of Integrative Medicine Research at The University of Texas MD Anderson Cancer Center, discusses caregiver burden in spouses of patients with lung cancer.

Carolyn Lefkowits, MD, MPH, MS, assistant professor, University of Colorado Denver, discusses patients' needs for palliative care in gynecologic oncology. 

Rudolph Navari, MD, PhD, professor of Medicine at Indiana University School of Medicine -South Bend, discusses traditional antiemetic treatment for chemotherapy-induced nausea and vomiting (CINV).

Alison Morris, RN, OCN, a Hematology/Oncology nurse practitioner at Stanford Health Care, discusses screening patients with cancer for emotional and physical distress as well as developing a nurse-led algorithm to categorize distress.

Brian Untch, MD, assistant member, Department of Surgery, Gastric and Mixed Tumor Service, Head and Neck Service, Memorial Sloan Kettering Cancer Center, discusses the watchful waiting approach for patients with neuroendocrine tumors (NETs).

Lara Traeger, PhD, psychologist at Massachusetts General Hospital and assistant professor at Harvard Medical School, discusses challenges in studying burnout among nurses.

Amelie Harle, MD, PhD, an oncologist at the Christie Hospital in Manchester, United Kingdom, discusses future tests to determine the efficacy of aprepitant (Emend) in reducing cough in patients with lung cancer.

Areej El-Jawahri, MD, an oncologist at Massachusetts General Hospital, discusses potentially avoidable hospitalizations among patients older than age 60 with acute myeloid leukemia.

Kavita Dharmarajan, MD, MSc, assistant professor of radiation oncology and palliative medicine at the Icahn School of Medicine at Mount Sinai Hospital, discusses palliative radiation oncology referrals.